A new survey reveals U.S. adults' growing interest in GLP-1 weight-loss drugs like Wegovy and Ozempic, with younger generations showing a shift toward injectables over traditional diet methods.
New research reveals that GLP-1 medications, known for weight loss, may also protect brain health by reducing inflammation. Discover how the fitness industry, with brands like Life Time and Equinox, is adapting to this medical shift.
The U.S. Department of Justice has filed a lawsuit against LA Fitness, alleging violations of the Americans with Disabilities Act. The lawsuit claims accessibility barriers at gym locations nationwide. Learn more about the case and the company's response.